Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.2
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 15561713
Basak C, et al. (2005) NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages. J Biol Chem 280, 4279-88 15561713
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S376-p - CASP1 (human)
Modsite: IFRKVRFsFEQPDGR SwissProt Entrez-Gene
Orthologous residues
CASP1 (human): S376‑p, CASP1 iso4 (human): S235‑p, CASP1 (mouse): S374‑p, CASP1 (rat): S374‑p
Downstream Regulation
Effect of modification (function):  enzymatic activity, induced

S9-p - GSK3B (human)
Modsite: SGRPRttsFAEsCkP SwissProt Entrez-Gene
Orthologous residues
GSK3B (human): S9‑p, GSK3B iso2 (human): S9‑p, GSK3B (mouse): S9‑p, GSK3B (rat): S9‑p, GSK3B (rabbit): S9‑p
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
LPS increase
wortmannin LPS inhibit treatment-induced increase

T180-p - P38A (human)
Modsite: RHtDDEMtGyVAtRW SwissProt Entrez-Gene
Orthologous residues
P38A (human): T180‑p, P38A iso2 (human): T180‑p, P38A (mouse): T180‑p, P38A iso3 (mouse): T180‑p, P38A (rat): T180‑p, P38A (salmonid): T181‑p
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
LPS PAK1 (human) no change compared to control PAK1 WT
LPS PAK1 (human) no change compared to control PAC1 KD
LPS increase
wortmannin LPS inhibit treatment-induced increase
A-443654 LPS inhibit treatment-induced increase

Y182-p - P38A (human)
Modsite: tDDEMtGyVAtRWYR SwissProt Entrez-Gene
Orthologous residues
P38A (human): Y182‑p, P38A iso2 (human): Y182‑p, P38A (mouse): Y182‑p, P38A iso3 (mouse): Y182‑p, P38A (rat): Y182‑p, P38A (salmonid): Y183‑p
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
LPS PAK1 (human) no change compared to control PAK1 WT
LPS PAK1 (human) no change compared to control PAC1 KD
LPS increase
wortmannin LPS inhibit treatment-induced increase
A-443654 LPS inhibit treatment-induced increase

S199-p - PAK1 (human)
Modsite: PRPEHtKsVyTRsVI SwissProt Entrez-Gene
Orthologous residues
PAK1 (human): S199‑p, PAK1 (mouse): S199‑p, PAK1 (rat): S198‑p
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
LPS increase
wortmannin LPS inhibit treatment-induced increase
LPS increase
A-443654 LPS inhibit treatment-induced increase
wortmannin LPS inhibit treatment-induced increase
LPS Akt1 (human) increase
LPS increase
wortmannin LPS Akt1 (human) inhibit treatment-induced increase
LPS Akt1 (human) increase Akt1 WT
LPS LPS Akt1 (human) Akt1 (human) no effect upon treatment-induced increase Akt1 DN
LPS increase vector
LPS LPS RAC1 (human) inhibit treatment-induced increase Rac 1 DN

S204-p - PAK1 (human)
Modsite: tKsVyTRsVIEPLPV SwissProt Entrez-Gene
Orthologous residues
PAK1 (human): S204‑p, PAK1 (mouse): S204‑p, PAK1 (rat): S203‑p
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
LPS increase
wortmannin LPS inhibit treatment-induced increase
LPS Akt1 (human) increase
LPS increase
wortmannin LPS Akt1 (human) inhibit treatment-induced increase
LPS Akt1 (human) increase Akt1 WT
LPS LPS Akt1 (human) Akt1 (human) no effect upon treatment-induced increase Akt1 DN
LPS increase vector
LPS LPS RAC1 (human) inhibit treatment-induced increase Rac 1 DN